COMMUNIQUÉS West-GlobeNewswire

Digirad Corporation Reports Financial Results for the First Quarter Ended March 31, 2019
03/05/2019
Performs within expectations, highlighted by DIS growth in revenue of 7% year over year Closed asset-based loan of $20 million with Sterling National Bank Made significant progress towards “HoldCo” transformation by [...]
Dentsply Sirona Reports Solid First Quarter 2019 Results
03/05/2019
Reported Q1 revenues of $946.2 million, declined 1.0% versus prior year and increased 3.9% on an internal sales growth basis. Q1 2019 US GAAP EPS of $0.17 vs. $0.35 in Q1 2018. Q1 2019 Non-US GAAP EPS of $0.49 compared [...]
HMS Reports First Quarter 2019 Financial Results
03/05/2019
Total Revenue of $148.0 Million, +4.7% vs. 1Q’18 (+11.3% excluding Medicare RAC Reserve Release in 1Q’18) GAAP EPS of $0.22 Per Diluted Share, Including Discrete Tax Benefits of $0.07 Per Diluted Share Adjusted EPS of $ [...]
Novo Nordisk's operating profit increased by 14% in Danish kroner and by 8% at constant exchange rates (CER) in the first three months of 2019
03/05/2019
Sales increased by 9% in Danish kroner and by 4% at CER to DKK 29.3 billion. Operating profit growth of 8% at CER was positively impacted by a reversal of write-downs of oral semaglutide prelaunch inventory. Sales in [...]
Nicox Presents First Data on Promising New Class of Nitric Oxide (NO)-Donating Compounds for Glaucoma at the ARVO 2019 Annual Meeting
03/05/2019
Press Release Nicox Presents First Data on Promising New Class of Nitric Oxide (NO)-Donating Compounds for Glaucoma at the ARVO 2019 Annual Meeting Nitric oxide (NO)-donating phosphodiesterase-5 (PDE5) inhibitors [...]
Nicox : Premières données d’une nouvelle classe prometteuse de donneurs d’oxyde nitrique (NO) pour le glaucome présentées au congrès ARVO 2019
03/05/2019
Communiqué de presse Nicox : Premières données d’une nouvelle classe prometteuse de donneurs d’oxyde nitrique (NO) pour le glaucome présentées au congrès ARVO 2019 Les donneurs d’oxyde nitrique (NO) inhibiteurs de la [...]
MDxHealth: Presentation of New Data for MDxHealth's Prostate Cancer Diagnostic Tests at AUA 2019 Annual Meeting
03/05/2019
PRESS RELEASE Moderated posters feature clinical validations of SelectMDx and ConfirmMDx IRVINE, CA, and HERSTAL, BELGIUM - MAY 3, 2019 - MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular [...]
MDxHealth (R) :
03/05/2019
Acacia Pharma Receives Complete Response Letter From Fda for Barhemsys®
03/05/2019
ACACIA PHARMA RECEIVES COMPLETE RESPONSE LETTER FROM FDA FOR BARHEMSYS ® This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Cambridge, UK and [...]
ObsEva SA Reports Consistent Long-Term Findings from Phase 2b EDELWEISS trial of Linzagolix for Endometriosis-Associated Pain
03/05/2019
Geneva, Switzerland and Boston, MA – May 3, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Tetra Bio-Pharma’s Subsidiary, Panag Pharma, Obtains Health Canada Authorization to Commence Its First Veterinary Clinical Study
03/05/2019
Commences Path Towards Approval in Lucrative Companion Animal Market OTTAWA, May 02, 2019 (GLOBE NEWSWIRE) -- Panag Pharma Inc. (Panag), a subsidiary of Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX-V: TBP [...]
Guardant Health to Report First Quarter 2019 Financial Results on May 9, 2019
03/05/2019
REDWOOD CITY, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the first quarter 2019 after market close on Thursday, May 9, 2019. Company [...]
RadNet, Inc. Announces Date of its First Quarter 2019 Financial Results Conference Call
03/05/2019
LOS ANGELES, May 02, 2019 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) , a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient [...]
Avricore Health Announces Late Filing of Annual Financial Statements and Management Cease Trade Order
02/05/2019
Vancouver, May 02, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR) (“Avricore Health” or the “Company”) announced today that as a result of delays in completion of its audit, the Company did not file its [...]
Resverlogix Announces 3-Month Loan Extension
02/05/2019
CALGARY, Alberta, May 02, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX: RVX) today announces that it has entered into an amending agreement with Third Eye Capital (acting as agent for [...]
European Medicines Agency Recommends Orphan Drug Designation for Relacorilant to Treat Patients with Cushing’s Syndrome
02/05/2019
MENLO PARK, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic [...]
Osmotica Pharmaceuticals plc to Provide First Quarter 2019 Business and Financial Update on May 9, 2019
02/05/2019
BRIDGEWATER, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (“Osmotica” or the “Company”) (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced that the Company will release [...]
R1 to Present at the Bank of America Merrill Lynch 2019 Health Care Conference
02/05/2019
CHICAGO, May 02, 2019 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced its management team will present [...]
Dynavax Announces First Patient Enrolled in Study of HEPLISAV-B® [Hepatitis B Vaccine, Recombinant (Adjuvanted)] in Adults With End-Stage Renal Disease
02/05/2019
Trial to evaluate immunogenicity and safety of Hepatitis B vaccine, HEPLISAV-B, in patients with end-stage renal disease who are initiating or undergoing dialysis BERKELEY, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- [...]

Pages